Back to Ovarian Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT01869400

NCT01869400
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You must be a woman aged 18 or older (there is no maximum age limit)
  • You must have ovarian cancer that came back after treatment and previously responded well to platinum-based chemotherapy
  • You must be willing and able to give written consent to take part before joining the study

Who may not be able to join:

  • Anyone who does not meet the safety requirements listed in the official product information for the treatment being studied (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
PharmaMar, Spain
Registry
clinicaltrials_gov
Start date
1 April 2013
Est. completion
1 December 2016

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

safety and tolerability data of the study therapy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov